This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor



Published: June 15, 2011


In the article "Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications" by Ni A. Khin, MD, and colleagues published in the April 2011 issue (J Clin Psychiatry 2011;72[4]:464-472), the legend for Figures 1, 2A, and 3 has been corrected online to "△ Trial with mean baseline HDRS score < 20" and "■  Trial with mean baseline HDRS score ≥ 20"; and the legend for Figure 2B has been corrected to "■  Trial with mean baseline HDRS score ≥ 20." The staff regret the errors.

Volume: 72

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!


Already registered? Sign In


LAI Antipsychotics in Schizophrenia: Long-term Outcomes of Early Use

Using data from the...